Literature DB >> 19207295

Psychometric properties of the WeeFIM in children with cerebral palsy in Turkey.

Birkan Sonel Tur1, Ayşe A Küçükdeveci, Sehim Kutlay, Güneş Yavuzer, Atilla H Elhan, Alan Tennant.   

Abstract

The Functional Independence Measure for Children (WeeFIM) instrument has recently been adapted and validated for non-disabled children in Turkey. The aim of this study was to validate the instrument in children with cerebral palsy (CP). One hundred and thirty-four children with CP were assessed using the WeeFIM. Reliability was tested by internal consistency, intraclass and interrater correlation coefficients (ICCs), internal construct validity by Rasch analysis, and external construct validity by correlation with the Denver II Development Test (Denver II). Mean age of the participants (70 females, 64 males) was 4y 6mo (SD 3y 8mo, range 6mo-16y). CP type was: diplegia in 37.3%, hemiplegia in 20.2%, quadriplegia in 8.2%, 'baby at risk' (i.e. infants who show neuromotor delay but cannot be classified in a CP type) in 29.9%, and other in 4.5%. Reliability of the WeeFIM was excellent with high Cronbach's alpha and ICC values ranging between 0.91 and 0.98 for the motor and cognitive scales. After collapsing response categories, both motor and cognitive scales met Rasch model expectations. Unidimensionality of the motor scale was confirmed after adjustment for local dependency of items. There was no substantive differential item functioning and strict unidimensionality for both scales was shown by analysis of the residuals. External construct validity was supported by expected high correlations with developmental ages determined by the social, fine motor function, language, and gross motor function domains of the Denver II. We conclude that the WeeFIM is a reliable and valid instrument for evaluating the functional status of Turkish children with CP.

Entities:  

Mesh:

Year:  2009        PMID: 19207295     DOI: 10.1111/j.1469-8749.2008.03255.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

Review 1.  Valid and reliable instruments for arm-hand assessment at ICF activity level in persons with hemiplegia: a systematic review.

Authors:  Ryanne J M Lemmens; Annick A A Timmermans; Yvonne J M Janssen-Potten; Rob J E M Smeets; Henk A M Seelen
Journal:  BMC Neurol       Date:  2012-04-12       Impact factor: 2.474

2.  The development and evaluation of content validity of the Zambia Spina Bifida Functional Measure: Preliminary studies.

Authors:  Margaret M Mweshi; Seyi L Amosun; Mary P Shilalukey-Ngoma; Esther Munalula-Nkandu; Zuhayr Kafaar
Journal:  Afr J Disabil       Date:  2017-07-24

3.  Effectiveness of Functional Electrical Stimulation - Cycling Treatment in Children with Cerebral Palsy.

Authors:  Natalya Özen; Ece Unlu; Ozgur Zeliha Karaahmet; Eda Gurcay; Ibrahim Gundogdu; Ebru Umay
Journal:  Malawi Med J       Date:  2021-09       Impact factor: 0.875

4.  Validity and Reliability of Functional Independence Measure for Children (WeeFIM) for Children With Cerebral Palsy.

Authors:  Goen-Woo Kim; Hyub Kim; Ju-Yeong Jeon; Jong-Sik Jang
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 1.730

5.  Rehabilitation outcomes in children with cerebral palsy during a 2 year period.

Authors:  Afitap İçağasıoğlu; Erkan Mesci; Yasemin Yumusakhuylu; Selin Turan Turgut; Sadiye Murat
Journal:  J Phys Ther Sci       Date:  2015-10-30

6.  How Did the Lockdown Imposed Due to COVID-19 Affect Patients With Cerebral Palsy?

Authors:  Bilinc Dogruoz Karatekin; Afitap İcagasioglu; Seyma Nur Sahin; Gülnihal Kacar; Fethullah Bayram
Journal:  Pediatr Phys Ther       Date:  2021-10-01       Impact factor: 1.452

7.  The contribution of neurocognitive situation, physical capacity and daily life activities to quality of life in childhood acute lymphoblastic leukemia survivors

Authors:  Elif Keleş Gülnerman; Yağmur Çam; Bülent Elbasan; Şebnem Soysal; Zühre Kaya; Idil Yenicesu; Ülker Koçak
Journal:  Turk J Med Sci       Date:  2021-10-21       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.